MARY ELIZABETH CAMPBELL: Open Payments
NPI 1942799838 · GRANGER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,360 in 77 payments from 19 companies in 2025. Trend: 2023 $1,418 · 2024 $1,669 · 2025 $1,360
Food & beverage: $1,360
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $214 |
| AstraZeneca Pharmaceuticals LP | 10 | $186 |
| PFIZER INC. | 15 | $169 |
| Lilly USA, LLC | 8 | $133 |
| Otsuka America Pharmaceutical, Inc. | 4 | $111 |
| ABBVIE INC. | 3 | $76 |
| Abbott Laboratories | 3 | $68 |
| Merck Sharp & Dohme LLC | 4 | $67 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
Products named: REXULTI, NURTEC ODT, Wegovy, AIRSUPRA, JARDIANCE, FARXIGA, FREESTYLE LIBRE 3, Rybelsus.
Industry payments across IN — which companies pay providers there.
